Rhys D O Jones (Rhys DO Jones)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Cross Sectional

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Diffusion Weighted

Top Venues

CPT: pharmacometrics & systems pharmacology

Science translational medicine

British journal of pharmacology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Srinivas Mamidi, Kim Maratea, Matthew Griffin, Rebecca Sargeant, Jelena Urosevic, Anton I Rosenbaum, Jiaqi Yuan, Krishna C Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D O Jones, Jerome T Mettetal
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rhys D O Jones, Klas Petersson, Areya Tabatabai, Larry Bao, Helen Tomkinson, Alwin G Schuller
Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib Plus Osimertinib in an EGFR-Mutation Positive, MET-Amplified Non-Small Cell Lung Cancer Model. Molecular cancer therapeutics (2023)
Erica Banks, Michael Grondine, Deepa Bhavsar, Evan Barry, Jason G Kettle, Venkatesh Pilla Reddy, Crystal Brown, Haiyun Wang, Jerome T Mettetal, Teresa Collins, Oladipupo Adeyemi, Ross Overman, Deborah Lawson, Alexander R Harmer, Corinne Reimer, Lisa Drew, Martin J Packer, Sabina Cosulich, Rhys D O Jones, Wenlin Shao, David Wilson, Sylvie M Guichard, Stephen E Fawell, Rana Anjum
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors. Science translational medicine 12 (541) (2021)
Rhys D O Jones, Mike Grondine, Alexandra Borodovsky, Maryann San Martin, Michelle DuPont, Celina D'Cruz, Alwin Schuller, Ryan Henry, Evan Barry, Lillian Castriotta, Rana Anjum, Klas Petersson, Tarjinder Sahota, Ghada F Ahmed
A pharmacokinetic-pharmacodynamic model for the MET tyrosine kinase inhibitor, savolitinib, to explore target inhibition requirements for anti-tumour activity. British journal of pharmacology 178 (3) (2020)